The Effects of Gevokizumab in Corticosteroid-resistant Subjects With Autoimmune Inner Ear Disease

Inclusion Criteria: * Autoimmune Inner Ear Disease with active deterioration in at least one ear * Failure to respond to a trial of high-dose corticosteroid therapy * Contraceptive measures adequate to prevent pregnancy during the study Exclusion Criteria: * Evidence of retrocochlear pathology (vestibular schwannoma) or inner ear malformation (Mondini Malformation or Enlarged Vestibular Aqueduct) * History of active or chronic infections * Currently receiving, or having received treatment for a malignancy in the past three years * Hearing loss that coincides with significant, disabling episodes of vertigo * History of allergic or anaphylactic reactions to monoclonal antibodies * Female subjects who are pregnant, planning to become pregnant, have recently delivered, or are breast-feeding Other protocol-defined inclusion/exclusion criteria may apply